{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:30Z","timestamp":1740107730634,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10067-019-04689-w","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T06:02:41Z","timestamp":1563861761000},"page":"2959-2961","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response: Leflunomide: potential treatment and cause of alopecia areata"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-2043","authenticated-orcid":false,"given":"Greg","family":"Koller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"key":"4689_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245","journal-title":"Clin Pharmacol Ther"},{"key":"4689_CR2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s10067-019-04577-3","volume":"38","author":"G Koller","year":"2019","unstructured":"Koller G, Cusnir I, Hall J, Ye C (2019) Reversible alopecia areata: a little known side effect of leflunomide. Clin Rheumatol 38:2015\u20132016. https:\/\/doi.org\/10.1007\/s10067-019-04577-3","journal-title":"Clin Rheumatol"},{"key":"4689_CR3","doi-asserted-by":"publisher","unstructured":"Mazloom SE, Yan D, Hu JZ, Ya J, Husni ME, Warren CB, Fernandez AP (2018) TNF-\u03b1 inhibitor-induced psoriasis: a decade of experience at the Cleveland Clinic. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.018","DOI":"10.1016\/j.jaad.2018.12.018"},{"key":"4689_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/DAD.0b013e3181ef7403","volume":"33","author":"LA Doyle","year":"2011","unstructured":"Doyle LA, Sperling LC, Baksh S, Lackey J, Thomas B, Vleugels RA, Qureshi AA, Velazquez EF (2011) Psoriatic alopecia\/alopecia areata-like reactions secondary to anti-tumor necrosis factor-\u03b1 therapy: a novel cause of noncicatricial alopecia. Am J Dermatopathol 33:161\u2013166. https:\/\/doi.org\/10.1097\/DAD.0b013e3181ef7403","journal-title":"Am J Dermatopathol"},{"key":"4689_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2310\/7750.2008.07095","volume":"13","author":"C Kirshen","year":"2009","unstructured":"Kirshen C, Kanigsberg N (2009) Alopecia areata following adalimumab. J Cutan Med Surg 13:48\u201350. https:\/\/doi.org\/10.2310\/7750.2008.07095","journal-title":"J Cutan Med Surg"},{"key":"4689_CR6","doi-asserted-by":"crossref","unstructured":"Mel\u00e9-Ninot G, Exp\u00f3sito-Serrano V, Quintana Codina M et al (2017) Adalimumab-related alopecia in a patient affected by psoriasis. Dermatol Online J:23.\u00a0 https:\/\/escholarship.org\/uc\/item\/3vm9z8qm . Accessed 3 July 2019","DOI":"10.5070\/D3237035733"},{"key":"4689_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/09273940802596559","volume":"17","author":"Y Pan","year":"2009","unstructured":"Pan Y, Rao NA (2009) Alopecia areata during etanercept therapy. Ocul Immunol Inflamm 17:127\u2013129. https:\/\/doi.org\/10.1080\/09273940802596559","journal-title":"Ocul Immunol Inflamm"},{"key":"4689_CR8","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jaad.2014.03.005","volume":"70","author":"M Tauber","year":"2014","unstructured":"Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Br\u00e9naut E, Hopp\u00e9 E, Bertolotti A, Bardin T, Delaporte E, Allez M, Bachelez H, Seneschal J, Viguier M (2014) Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study. J Am Acad Dermatol 70:1146\u20131149. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.005","journal-title":"J Am Acad Dermatol"},{"key":"4689_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","volume":"10","author":"D Wendling","year":"2014","unstructured":"Wendling D, Prati C (2014) Paradoxical effects of anti-TNF-\u03b1 agents in inflammatory diseases. Expert Rev Clin Immunol 10:159\u2013169. https:\/\/doi.org\/10.1586\/1744666X.2014.866038","journal-title":"Expert Rev Clin Immunol"},{"key":"4689_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/ijd.13691","volume":"56","author":"M Havmose","year":"2017","unstructured":"Havmose M, Thomsen SF (2017) Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases. Int J Dermatol 56:1087\u20131102. https:\/\/doi.org\/10.1111\/ijd.13691","journal-title":"Int J Dermatol"},{"key":"4689_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/isbn.978-3-318-06101-7","volume-title":"Adverse Reactions to Biologics","author":"Llu\u00eds Puig","year":"2017","unstructured":"Puig L (2018) Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others. In: Current problems in dermatology. pp 49\u201363.\u00a0 https:\/\/doi.org\/10.1159\/000479475"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04689-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:57:14Z","timestamp":1664017034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04689-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4689"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04689-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}